SWOG-9208 Quality of Life and Health Status in Patients With Stage I or Stage II Hodgkin's Disease
Completed
Conditions studied: Lymphoma, Psychosocial Effects of Cancer and Its Treatment
In brief
RATIONALE: Quality-of-life assessment in patients undergoing cancer treatment may help determine the intermediate- and long-term effects of treatment on patients with cancer. PURPOSE: This clinical trial studies the impact of therapy on the health status and quality of life of patients with stage I or stage II Hodgkin's disease who are receiving radiation therapy with or without chemotherapy.
Key facts
- Study ID
- NCT00002563
- Run by
- SWOG Cancer Research Network
- People needed
- 263
- Starts
- 1994-04-01
- Expected to finish
- 2005-05-01
- Last updated by the study team
- 2013-04-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- Ellis Fischel Cancer Center - Columbia — Columbia, Missouri, United States
- Barnes-Jewish Hospital — St Louis, Missouri, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Beth Israel Medical Center — New York, New York, United States
- State University of New York - Upstate Medical University — Syracuse, New York, United States
- Comprehensive Cancer Center of Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- University of Tennessee, Memphis Cancer Center — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.